BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Cash Flow 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow | -57.6M | -72.0M | -155.0M | -135.3M | -82.2M | -66.3M | -27.1M | -13.5M | -2.2M |
| Depreciation & Amort. | — | — | — | — | 297,000 | 188,000 | 156,000 | 17,000 | 1,000 |
| Investing Activities | |||||||||
| Capital Expenditure | 0 | 0 | 20,000 | 139,000 | 445,000 | 316,000 | 870,000 | 340,000 | — |
| Free Cash Flow | -57.6M | -72.0M | -155.0M | -135.5M | -82.6M | -66.7M | -28.0M | -13.8M | — |
| Financing Activities | |||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | 9.0M | — | — | — |
BioXcel Therapeutics, Inc. Cash Flow — FAQ
BioXcel Therapeutics, Inc. (BTAI) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's cash flow history?
The chart and table above show BioXcel Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.